Arteriovenous grafts are associated with earlier catheter removal and fewer catheter days in the United States Renal Data System population

Journal of Vascular Surgery
Andrew E LeakeMichel S Makaroun

Abstract

Arteriovenous fistulas (AVFs) are associated with improved long-term outcomes but longer maturation times and higher primary failure rates compared with arteriovenous grafts (AVGs). The Fistula First Breakthrough Initiative has recently emphasized tunneled dialysis catheter (TDC) avoidance. We sought to characterize the relationship of AVFs and AVGs to the use of TDCs as well as secondary procedures. Using the United States Renal Data System (USRDS) database, we identified incident hemodialysis (HD) patients in 2005 that started HD with a TDC and survived at least 1 year. We then monitored them through 2008. Access creation, TDC removal, TDC placement, and secondary procedures were identified by Current Procedural Terminology codes (American Medical Association, Chicago, Ill). Multivariate logistic regression was used to identify risk factors for the primary end points. In 2005, HD was initiated in 56,495 patients, 74% with a TDC. Of these, 6286 had an access procedure ≤3 months and 1 year of follow-up (AVF, 4634; AVG, 1652). Mean age was 67.7 years (AVF, 67.3; AVG, 68.7 years; P < .001), 53.3% were men (AVF, 58.1%; AVG, 40.5%; P < .001), and 33.8% were obese (AVF, 33.6%; AVG, 34.4%; P = not significant). AVG placement was asso...Continue Reading

References

Aug 17, 2002·Annals of Vascular Surgery·James K FullertonKim J Hodgson
Sep 18, 2002·Kidney International·Michael Allon, Michelle L Robbin
Mar 25, 2005·Journal of the American Society of Nephrology : JASN·Brad C AstorUNKNOWN CHOICE Study
Sep 1, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Timmy LeeMichael Allon
May 4, 2007·Journal of the American Society of Nephrology : JASN·Timmy LeeMichael Allon
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Brian D BradburyBrenda W Gillespie
Aug 28, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eduardo LacsonRaymond M Hakim
Feb 5, 2008·Journal of Vascular Surgery·Andre BiuckiansMarc H Glickman
Feb 8, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Henricus J T HuijbregtsUNKNOWN CIMINO study group
May 15, 2008·JAMA : the Journal of the American Medical Association·Laura M DemberUNKNOWN Dialysis Access Consortium Study Group
Jan 9, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Allan J CollinsShu-Chen Chen
Mar 17, 2010·BMJ : British Medical Journal·Linda E LévesqueSamy Suissa
Oct 30, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Michael Allon, Charmaine E Lok
Nov 24, 2012·Seminars in Dialysis·Louise M MoistTimmy C Lee
Jul 3, 2013·Journal of the American Society of Nephrology : JASN·Ranil N DeSilvaAlexander S Goldfarb-Rumyantzev

❮ Previous
Next ❯

Citations

Jan 20, 2016·Journal of Vascular Surgery·Lindsey M KoreptaPeter Y Wong
Mar 5, 2016·Seminars in Dialysis·Mariana Murea, Scott Satko
May 18, 2016·Journal of Vascular Surgery·Nathan K ItogaWei Zhou
Jan 9, 2017·Seminars in Dialysis·Michael Allon
May 8, 2018·Seminars in Dialysis·Candice Halinski, Holly M Koncicki
Jul 22, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Gerald A BeathardThomas S Huber
Dec 17, 2019·The Journal of Vascular Access·N A BradleyS Suttie
Sep 2, 2019·Irish Journal of Medical Science·Andrew S KuceyBrian J Manning
Sep 2, 2020·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Andrej SchmidtSteven Kum
Apr 2, 2019·Annals of Vascular Diseases·Kritaya KritayakiranaPunthita Aimsupanimitr
Jan 17, 2020·Journal of the American Society of Nephrology : JASN·Shipra AryaJason M Hockenberry
Feb 12, 2017·Vascular and Endovascular Surgery·Todd E RussellFedor Lurie
Aug 1, 2019·The Journal of Vascular Access·Karim M SalemEfthymios D Avgerinos
May 31, 2020·Journal of Vascular Surgery·Abhisekh MohapatraEfthymios D Avgerinos
Aug 12, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Charmaine E LokUNKNOWN National Kidney Foundation
Mar 9, 2021·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Ricardo Portiolli Franco
Jul 25, 2019·Journal of Vascular Surgery Cases and Innovative Techniques·Brian M FreemanChristopher G Carsten
Jun 26, 2017·Journal of Vascular Surgery·Isibor ArhuideseMahmoud Malas
Jun 25, 2019·Journal of Vascular Surgery·Jerry J KimHoussam K Younes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.